PRESS RELEASES

All Releases
Jan 08, 2001
Pain Therapeutics Announces Extension of Lock-Up Agreement SOUTH SAN FRANCISCO, Calif. - January 8, 2001 - Pain Therapeutics, Inc. (Nasdaq:PTIE), a developer of next generation opioid painkillers, today announced that officers, directors and venture capital investors who are principal shareholders
Oct 23, 2000
Pain Therapeutics Announces Positive Phase II Data for New Type of Morphine and Initiates Two New Phase II Clinical Trials SOUTH SAN FRANCISCO, Calif. - October 23, 2000 - Pain Therapeutics, Inc. (Nasdaq: PTIE) announced today that it has initiated two Phase IIb clinical trials on PTI-555, the
Oct 18, 2000
Pain Therapeutics Initiates Phase II Clinical Trial for New Painkiller SOUTH SAN FRANCISCO, Calif. - October 18, 2000 - Pain Therapeutics, Inc. (Nasdaq: PTIE), a developer of next-generation opioid pain medications, announced today the initiation of a Phase IIb clinical trial with PTI-601.
Oct 03, 2000
Pain Therapeutics Announces Positive Phase II Clinical Results for a New Type of Painkiller South San Francisco, Calif. - October 3, 2000 - Pain Therapeutics, Inc. (Nasdaq: PTIE), a developer of next generation opioid painkillers, today announced positive safety and efficacy results from a Phase II